The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU

Ankara City Hospital Bilkent160 enrolled

Overview

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

Study Type

OBSERVATIONAL

Enrollment

160

Conditions

Phosphate Deficiency Covid19 Mortality

Interventions

4C mortality scoreDIAGNOSTIC_TEST

4C mortality score and phosphate levels

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study Exclusion Criteria: * there is no exclusion criteria

Locations (1)

Ankara City Hospital

Ankara, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

4C mortality score

4C Mortality Scores of the patients will be calculated, according to age, gender, number of comorbidities, respiratory rate, SpO2, GCS, urea, and CRP parameters

Time frame: 6 months

serum phosphate levels

mg/dl

Time frame: 6 months

mortality

mortality percentage of patients in 28 days

Time frame: 28 days

Central Contacts

betül aytaç, MD

CONTACT

+905073578351 drbguven@hotmail.com

ismail aytaç, MD

CONTACT

+905056340369 aytacismail1972@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.